Table 1. Hemodynamic monitoring and pulmonary function before and after μsPEFs treatment.
| Parameter | Baseline | 0h | 6h | 24h | p value |
|---|---|---|---|---|---|
| HR | 126.0 ± 23 | 151.4 ± 7.8 | 134.0 ± 25.3 | 120.3 ± 30.1 | 0.8877 |
| MAP (mmHg) | 122.4 ± 4.9 | 140.81 ± 0.82 | 132.58 ± 1.62 | 126.77 ± 2.82 | 0.4827 |
| Temp (°C) | 36.02 ± 0.42 | 36.1 ± 0.44 | 35.9 ± 0.46 | 36.09 ± 0.32 | 0.9009 |
| PaCO2 (mmHg) | 29.3 ± 1.9 | 30.2 ± 2.9 | 30.4 ± 1.3 | 30.1 ± 1.2 | 0.7398 |
| PaO2 (mmHg) | 110.23 ± 12 | 119.4 ± 6.3 | 100.4 ± 12 | 121.4 ±10 | 0.5141 |
| Oxygen saturation | 100% | 95% | 98% | 99% | 1.000 |
| CVP (cm H2O) | 7.8 ± 1.3 | 8.1 ± 1.9 | 8.2 ± 1.4 | 7.6 ± 1.1 | 0.9122 |
Hemodynamic and pulmonary functions were monitored by ECG monitoring. HR, heart rate (times per minute); MAP, mean arterial pressure; Temp, core temperature; PaCO2, arterial carbon dioxide partial pressure; PaO2, arterial oxygen partial pressure; CVP, central venous pressure. A time course was presented by before treatment (baseline), during treatment (0 h), 6 hour post treatment (6 h) and 1 day after treatment (24 h). Data were expressed as mean ± SEM. The p value indicates statistical analysis between the baseline level and 24 h after μsPEFs treatment.